DBV Technologies (DBVT) Cash from Financing Activities (2014 - 2026)
DBV Technologies (DBVT) reported Cash from Financing Activities of $88.9 million for Q1 2026, down 44.11% on a QoQ basis from $159.1 million in Q4 2025.
DBV Technologies (DBVT) has 11 years of Cash from Financing Activities data on file, last reported at $88.9 million in Q1 2026.
- Quarterly Cash from Financing Activities changed N/A year-over-year to $88.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $365.1 million (up 56153.0% YoY) and the FY2025 annual result came in at $276.2 million, up 46949.74% from the prior year.
- Cash from Financing Activities retreated to $88.9 million in Q1 2026 per DBVT's latest filing, from $159.1 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $195.4 million in Q2 2022 and bottomed at -$837000.0 in Q3 2023.
- The 5-year median for Cash from Financing Activities is -$3500.0 (2023), against an average of $35.4 million.
- The widest annual swing landed in 2024, when Cash from Financing Activities tumbled 342.86%; it then soared 354621.21% in 2025.
- Tracing DBVT's Cash from Financing Activities over 5 years: stood at -$283000.0 in 2022, then jumped by 33.22% to -$189000.0 in 2023, then soared by 457.14% to $675000.0 in 2024, then soared by 23464.44% to $159.1 million in 2025, then sank by 44.11% to $88.9 million in 2026.
- Per Business Quant, the three latest DBVT Cash from Financing Activities figures stand at $88.9 million (Q1 2026), $159.1 million (Q4 2025), and $130000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | 88.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88.90 Mn |
| Mar 31, 2026 | 88.90 Mn |
| Dec 31, 2025 | 159.06 Mn |
| Dec 31, 2025 | 159.06 Mn |
| Sep 30, 2025 | 130,000.00 |
| Sep 30, 2025 | 130,000.00 |
| Jun 30, 2025 | 116.99 Mn |
| Jun 30, 2025 | 116.99 Mn |
| Dec 31, 2024 | 675,000.00 |
| Dec 31, 2024 | 675,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Jun 30, 2024 | -33,000.00 |
| Jun 30, 2024 | -33,000.00 |
| Mar 31, 2024 | -62,000.00 |
| Mar 31, 2024 | -62,000.00 |
| Dec 31, 2023 | -189,000.00 |
| Dec 31, 2023 | -189,000.00 |
| Sep 30, 2023 | -837,000.00 |
| Sep 30, 2023 | -837,000.00 |
| Jun 30, 2023 | 7.81 Mn |
| Jun 30, 2023 | 7.81 Mn |
| Mar 31, 2023 | -14,000.00 |
| Mar 31, 2023 | -14,000.00 |
| Dec 31, 2022 | -283,000.00 |
| Dec 31, 2022 | -283,000.00 |
| Sep 30, 2022 | -818,000.00 |
| Sep 30, 2022 | -818,000.00 |
| Jun 30, 2022 | 195.35 Mn |
| Jun 30, 2022 | 195.35 Mn |
| Mar 31, 2022 | -129,000.00 |
| Mar 31, 2022 | -129,000.00 |
| Dec 31, 2021 | 377,000.00 |
| Dec 31, 2021 | 377,000.00 |
| Sep 30, 2021 | -1.17 Mn |
| Sep 30, 2021 | -1.17 Mn |
| Jun 30, 2021 | 631,000.00 |
| Jun 30, 2021 | 631,000.00 |
| Mar 31, 2021 | 440,000.00 |
| Mar 31, 2021 | 440,000.00 |
| Dec 31, 2020 | -76,000.00 |
| Dec 31, 2020 | -76,000.00 |
| Sep 30, 2020 | -1.05 Mn |
| Sep 30, 2020 | -1.05 Mn |
| Jun 30, 2020 | 61,000.00 |
| Jun 30, 2020 | 61,000.00 |
| Mar 31, 2020 | 150.61 Mn |
| Mar 31, 2020 | 150.61 Mn |
| Dec 31, 2019 | 62.71 Mn |
| Dec 31, 2019 | 62.71 Mn |
| Sep 30, 2019 | 69.46 Mn |
| Sep 30, 2019 | 69.46 Mn |
| Dec 31, 2018 | -151.58 Mn |
| Dec 31, 2018 | -151.58 Mn |
| Sep 30, 2018 | 153.32 Mn |
| Sep 30, 2018 | 153.32 Mn |
| Dec 31, 2015 | 3.48 Mn |
| Dec 31, 2015 | 3.48 Mn |
| Dec 31, 2014 | 937,375.11 |
| Dec 31, 2014 | 937,375.11 |